U.S. regulators have strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
Moderna and Pfizer shots over J&J's because of its safety issues.
The J&J vaccine will carry a starker warning about potential “long-term and debilitating health consequences” of the side effect. The clotting problems first came up last spring, with the J&J shot in the U.S. and with a similar vaccine made by AstraZeneca that is used in other countries. At that time,
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
FDA puts strict limits on Johnson & Johnson Covid-19 vaccineThe US Food and Drug Administration announced Thursday that it is limiting the emergency use authorization of the Johnson & Johnson/Janssen Covid-19 vaccine to people 18 and older for whom other vaccines aren't appropriate or accessible and those who opt for J&J because they wouldn't otherwise get vaccinated.
Consulte Mais informação »
FDA announces limits on who can receive Johnson & Johnson COVID-19 vaccineThe reason is a rare, but serious risk of blood clots.
Consulte Mais informação »
Johnson & Johnson Covid-19 Vaccine Use Limited By US Food And Drug Administration AdvisoryThe claims that Covid-19 vaccine are “safe and effective” now comes with a “But.” The US Food and Drug Administration announced Thursday that the Johnson & Johnson/Janss…
Consulte Mais informação »
FDA restricts Johnson & Johnson COVID-19 vaccine due to blood clot riskThe Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J's vaccine.
Consulte Mais informação »
FDA restricts Johnson & Johnson's COVID-19 vaccine due to blood clot riskU.S. regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots.
Consulte Mais informação »
FDA restricts Johnson & Johnson's COVID-19 vaccine due to rare but serious risk of blood clotsU.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
Consulte Mais informação »